| > |
Jeanne M. Rogers, RN,
MEd, Associate Executive Director of the Abramson
Cancer Center of the University of Pennsylvania and
Administrative Director, of the University of Pennsylvania
Cancer Network, was recently appointed to serve on
the Pennsylvania Cancer Control, Prevention and Research Advisory
Board. |
| > |
The board’s primary function is to
advise the Secretary of Health on matters related to cancer;
approve a yearly plan for cancer control, prevention and research;
report annually to the General Assembly; and recommend the awarding
of grants and contracts related to cancer control, prevention
and research. |
| > |
Rogers, who has been with Penn’s Abramson
Cancer Center since 1993, was recently elected to the Board of
Directors of the Association of Cancer Executives (ACE) and serves
on its 2008 Conference Planning Committee. In addition, Rogers
serves on the Pennsylvania Department of Health’s Breast
and Cervical Cancer Technical Review Committee. She is also a
member of the Oncology Nursing Society (ONS) and the American
Society of Clinical Oncology (ASCO). |
(PHILADELPHIA) — Jeanne
M. Rogers, RN, MEd, Associate
Executive Director of the Abramson Cancer Center of the
University of Pennsylvania and Administrative Director,
of the University
of Pennsylvania Cancer Network, was recently appointed
to serve on the Pennsylvania
Cancer Control, Prevention and Research Advisory Board.
 |
Jeanne Rogers, RN, MEd
Click on thumbnail
to view full-size image |
“It is an honor to be asked to serve on the Advisory Board,” said
Rogers. “This vital group plays an instrumental role in
advising the Pennsylvania state Secretary
of Health and the Governor on issues related to cancer prevention, screening, treatment and
research that are of interest to the citizens of the Commonwealth.
Our small, but diverse group has one ultimate goal and that is
to provide cancer patients and their families access to affordable
state-of-the-art care.”
The Pennsylvania Cancer Control, Prevention and Research Advisory
Board has 11 members, including the Secretary of Health and ten
other members appointed by the governor and confirmed by the Senate,
for four-year terms. The panel consists of three physicians, one
nurse, one health care administrator, two public health professionals,
one community health nurse, and three citizens.
The board’s primary function is to advise the Secretary of
Health on matters related to cancer; approve a yearly plan for
cancer control, prevention and research; report annually to the
General Assembly; and recommend the awarding of grants and contracts
related to cancer control, prevention and research.
Rogers, who has been with Penn’s Abramson Cancer Center
since 1993, was recently elected to the Board
of Directors of the
Association of Cancer
Executives (ACE) and serves on its 2008 Conference
Planning Committee. In addition, Rogers serves on the Pennsylvania
Department of Health’s Breast
and Cervical Cancer Technical Review Committee. She is also a member of the Oncology
Nursing Society (ONS) and the American
Society of Clinical Oncology (ASCO).
Rogers resides in Doylestown, PA.
# # #
The Abramson Cancer Center (ACC) of the University
of Pennsylvania is a national leader in cancer research,
patient care, and education. The pre-eminent position of the
Cancer Center is reflected in its continuous designation as
a Comprehensive Cancer Center by the National Cancer Institute
for 30 years, one of 39 such Centers in the United States.
The ACC is dedicated to innovative and compassionate cancer
care. The clinical program, comprised of a dedicated staff
of physicians, nurse practitioners, nurses, social workers,
physical therapists, nutritionists and patient care coordinators,
currently sees over 50,000 outpatient visits, 3400 inpatient
admissions, and provides over 24,000 chemotherapy treatments,
and more than 65,000 radiation treatments. Not only is the
ACC dedicated to providing state-of-the-art cancer care, the
latest forms of cancer prevention, diagnosis, and treatment
are available to our patients through clinical themes that
developed in the relentless pursuit to eliminate the pain and
suffering from cancer. In addition, the ACC is home to the
300 research scientists who work relentlessly to determine
the pathogenesis of cancer. Together, the faculty is committed
to improving the prevention, diagnosis and treatment of cancer.
PENN Medicine is a $3.5 billion enterprise
dedicated to the related missions of medical education, biomedical
research, and excellence in patient care. PENN Medicine consists
of the University of Pennsylvania School of Medicine (founded
in 1765 as the nation's first medical school) and the University
of Pennsylvania Health System.
Penn's School of Medicine is ranked #2 in the nation for receipt
of NIH research funds; and ranked #3 in the nation in U.S. News
& World Report's most recent ranking of top research-oriented
medical schools. Supporting 1,400 fulltime faculty and 700 students,
the School of Medicine is recognized worldwide for its superior
education and training of the next generation of physician-scientists
and leaders of academic medicine.
The University of Pennsylvania Health System includes three hospitals,
all of which have received numerous national patient-care honors [Hospital
of the University of Pennsylvania; Pennsylvania Hospital, the nation's
first hospital; and Penn Presbyterian Medical Center]; a faculty practice
plan; a primary-care provider network; two multispecialty satellite
facilities; and home care and hospice.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.